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In this study we describe six Italian patients present-
ing an unusually mild variant of non-Herlitz
junctional epidermolysis bullosa associated with a
reduced expression of type XVII collagen. All
patients are homozygous for a novel nonsense muta-
tion (R795X) within exon 33 of COL17A1 and show
a common haplotype, attesting propagation of an
ancestral allele within the Italian population. Analysis
of patients' COL17A1 transcripts showed the
presence of two mRNA species: a normal-sized
mRNA carrying mutation R795X that undergoes
rapid decay, and a transcript generated by in-frame
skipping of exon 33. Patients' keratinocytes were
shown to synthesize minute amounts of type XVII
collagen, which appeared correctly localized along
the cutaneous basement membrane. We therefore
suggest that the exon 33-deleted COL17A1 splice
variant encodes for type XVII collagen molecules
that maintain a functional role and account for the
mild phenotype of our patients. Key words: alternative
splicing/COL17A1/non-Herlitz junctional epidermolysis
bullosa/nonsense mutation/recurrent mutation. J Invest
Dermatol 116:182±187, 2001
T
he hemidesmosome-anchoring ®lament complex
and anchoring ®brils are the ultrastructural hallmarks
of the basement membrane zone (BMZ) of strati®ed
epithelia. These specialized attachment structures
bridge cytoplasmic keratin ®laments of the basal
epithelial cells to the upper dermis and anchor the epithelium to the
underlying mesenchyme (Eady, 1998).
Type XVII collagen, also known as BP180, BPAG2, or HD4, is
a structural hemidesmosomal component encoded by a single copy
gene, COL17A1 (Nishizawa et al, 1993; Gatalica et al, 1997). The
ectodomain of this type II transmembrane molecule contains a
series of collagen-like repeats (Giudice et al, 1992) that associate in
homotrimeric structures (Hirako et al, 1996). The relevance of type
XVII collagen in ensuring adhesion of the epidermis to the dermis
was ®rst indicated by the presence of circulating autoantibodies
against type XVII collagen in patients affected with the acquired
autoimmune blistering skin disorders bullous pemphigoid and
herpes gestationis (Giudice et al, 1993). Using an experimental
animal model such antibodies have also been shown to induce
subepidermal blistering in vivo (Liu et al, 1995).
Several studies have since demonstrated that mutations in the
gene COL17A1 and in other genes encoding the major structural
proteins of the hemidesmosomes and the epithelial adhesion ligand
laminin-5 underlie junctional epidermolysis bullosa (JEB), a group
of recessively inherited bullous diseases of skin and mucosae in
which blister formation results from tissue separation within the
lamina lucida of the BMZ (Zambruno et al, 1998). According to
the revised classi®cation system for inherited epidermolysis bullosa,
three major subtypes can be distinguished within this group of
disorders: Herlitz (lethal) JEB, non-Herlitz (nonlethal) JEB, and
JEB with pylorica atresia (Fine et al, 2000). In particular, COL17A1
mutations have been associated with a non-Herlitz JEB variant
formerly termed generalized atrophic benign epidermolysis bullosa
(GABEB) (OMIM 226650), which is characterized by widespread
skin blistering healing with atrophy, alopecia, and normal life span
(Pulkkinen et al, 1999; references therein).
In this report, we investigated six patients from four Italian
families suffering from an unusually mild form of non-Herlitz JEB.
In all probands, a novel homozygous nonsense mutation within
exon 33 of COL17A1 was identi®ed. Through the analysis of
mutation consequences at the mRNA and protein levels, we
provide evidence for a minor alternatively spliced COL17A1
mRNA lacking exon 33, and residual synthesis and expression of
type XVII collagen at the cutaneous BMZ.
MATERIALS AND METHODS
Clinical ®ndings Four Italian families with members affected with non-
Herlitz JEB were studied.
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The clinical and immuno¯uorescence ®ndings of the probands in
families A and B, four individuals from two related families of an isolated
village in central Italy (Fig 1c), have been detailed elsewhere (Mazzanti et al,
1998).
The proband in family C (Fig 1c, C-II.1) was a 52-y-old woman who
had suffered from generalized cutaneous and occasional oral blistering since
birth. Her parents, both deceased, were not consanguineous and had never
presented skin lesions. The patient had grown and developed normally and
her skin condition had signi®cantly improved after puberty. Physical
examination revealed cutaneous blisters and atrophic scarring localized
exclusively at trauma sites, i.e., on hands, feet, elbows, and knees, as well as
nail dystrophy and dental abnormalities. The eyelashes, eyebrows, and scalp
hair were normal, whereas axillary and pubic hair were almost completely
absent.
The proband in family D (Fig 1c, D-II.1), a 33-y-old man born from
consanguineous healthy parents, had also developed skin blisters at birth.
His history and clinical manifestations were similar to those of proband C-
II.1. He did not show any alopecia, however.
Family D was from a small village in southern Italy, whereas family C
was from a town in central Italy 70 miles away from the village of families A
and B. In addition, families A/B, C, and D were not known to have any
common lineage.
In all patients, the diagnosis of non-Herlitz JEB was established on the
basis of the clinical examination, family history, and electron microscopy
analysis of skin specimens, which detected tissue separation within the
lamina lucida of the cutaneous BMZ (not shown).
Keratinocyte cultures A biopsy of a nonlesional skin area was obtained
from all patients. Keratinocyte cultures were established for four affected
individuals, a heterozygous healthy carrier, and healthy consenting controls,
as described by Zambruno et al (1995). In addition, keratinocytes from a
previously characterized type XVII collagen-de®cient GABEB patient
carrying the frameshift mutation 2342delG at the homozygous state were
used (Scheffer et al, 1997).
Immuno¯uorescence analysis Frozen skin sections 5 mm thick
obtained from skin biopsies of the probands C-II.1, D-II.1, and B-IV.1,
and a healthy volunteer were processed for immuno¯uorescence using a
three-step biotin-streptavidin-¯uorescein procedure as described by
Kanitakis et al (1989). The following monoclonal antibodies (MoAbs)
and polyclonal antisera were used: 1A8C (mouse MoAb, which recognizes
an epitope in the collagen XVII cytoplasmic part), 233 and 1D1 (mouse
MoAbs recognizing epitopes localized in the carboxy-terminal half of type
XVII collagen extracellular domain) (Nishizawa et al, 1993; Hirako et al,
1996), G0H3 (rat MoAb to the a6 integrin subunit; gift from A.
Sonnenberg, The Netherlands Cancer Institute, Amsterdam, The
Netherlands), 3E1 (mouse MoAb to the b4 integrin subunit; Telios
Pharmaceuticals, San Diego, CA), and GB3 (mouse MoAb to laminin-5).
Detection of mutation in type XVII collagen cDNA Total RNA,
extracted by lysis of the cell cultures in the presence of guanidine
isothiocyanate, was reverse-transcribed using the SuperScript RNase H free
reverse transcriptase (Life Technologies, San Giuliano Milanese, Milan,
Italy). The RNA of patients B-IV.2 and D-II.1 was extracted from a frozen
skin biopsy using a Micro-Scale total RNA Separator Kit (Clontech
Laboratories, Palo Alto, CA). These cDNAs were used as templates in
polymerase chain reactions (PCRs) with speci®c oligonucleotide primers,
designed from the published cDNA sequence (GenBank no. M91669), to
Figure 1. Identi®cation and veri®cation of
the homozygous mutation R795X in the pro-
bands' COL17A1 gene and inheritance in the
families. (a) Sequence analysis of the patients'
PCR products spanning exons 26±34. Compared
with normal cDNA (upper panel), a C®T transi-
tion at nucleotide position 2488 is evident in pa-
tients' cDNA (middle panel). In addition, a second
transcript carrying the in-frame skipping of exon
33 is present in patients' cells (lower panel). The
2488C®T transition converts the codon for argi-
nine CGA with the signal for premature termina-
tion of translation TGA at amino acid position
795. The mutation is therefore designated
R795X. Base substitution is underlined. (b) Total
genomic DNA from all affected individuals was
subjected to PCR using primers that amplify a
247 bp fragment encompassing exon 33. Com-
pared with a normal control (upper panel), direct
nucleotide sequencing of the non-Herliz JEB pa-
tients con®rms the presence of the 2488C®T
transition at the homozygous state (lower panel). (c)
Pedigrees of the non-Herlitz JEB families and ver-
i®cation of mutation 2488C®T with HaeIII re-
striction endonuclease digestion. Genomic DNA
ampli®cation of the region containing the muta-
tion, using sense primer 5¢-CTTGTTCTAATCA-
CATCA-3¢ and antisense primer 5¢
CCAGTGAAAAGAAAGAAA 3¢, results in the
synthesis of a 95 bp PCR product. The ampli®ca-
tion conditions were 95°C for 8 min; 94°C, 45 s;
48°C, 45 s; 72°C, 45 s (30 cycles); and extension
at 72°C for 10 min. Whereas the HaeIII digestion
of the PCR product yields two bands, 57 and 38
bp in size, in a normal control (lane C), in the
presence of the 2488C®T substitution the 95 bp
fragment is not digested. Patients A-V.1, A-V.2,
A-V.5, B-IV.1, C-II.1, and D-II.1 are all homo-
zygous for the mutation, whereas the healthy
mother of A-V.1 and A-V.2 and the son of A-V.5
are heterozygous. The corresponding PCR pro-
duct from the healthy individual A-V.4 is nor-
mally digested.
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produce 14 overlapping cDNA fragments of ~400 bp covering the entire
open reading frame of type XVII collagen (Giudice et al, 1992).
Speci®cally, primers used to amplify the 394 bp region of type XVII
collagen cDNA comprising exons 26±34 (nucleotides 2143±2536) were
sense primer 5¢-GGTCCTGTAGGTCTCCAAGG-3¢ (Pr 7L) and
antisense primer 5¢-AAGTCACGATCTTGCCTGGA-3¢ (Pr 7R). The
amplimers were analyzed on 2% agarose gel, subcloned into the PCR-TM
II vector (Invitrogen, Leek, The Netherlands), and subjected to automated
nucleotide sequencing (ABI PRISM, 377 DNA Sequencer, Perkin Elmer,
Branchburg, NJ).
Veri®cation of mutation at the genomic level Genomic DNA was
isolated from peripheral blood by standard procedures. Ampli®cation of
exon 33 of COL17A1 and its boundaries (247 bp) was performed using
primers placed on ¯anking introns (GenBank no. U76564) (Gatalica et al,
1997). PCR cycling conditions were 95°C for 8 min, 94°C for 45 s, 55°C
for 45 s, 72°C for 45 s (30 cycles), and extension at 72°C for 10 min. The
ampli®ed products were subjected to direct automated nucleotide
sequencing.
As the mutation detected in the COL17A1 gene abolishes a HaeIII
restriction site, HaeIII endonuclease digestion (New England Biolabs,
Beverly, MA) was used to con®rm the homozygous state of the mutation in
the patients, and to assess its inheritance in the families.
Search for alternatively processed COL17A1 transcripts Reverse
transcriptase PCR (RT-PCR) based tests were designed to assess the
presence of exon 33 alternatively processed transcripts. Total RNA was
obtained from cultured keratinocytes of healthy donors, four patients, the
heterozygous healthy carrier A-VI.1, 2342delG GABEB cells, and human
peripheral blood lymphocytes. A ®rst set of PCRs was performed using the
same primer pair (Pr 7L/Pr 7R) and ampli®cation conditions described
above. In a separate set of PCRs, the sense primer Pr 7L was used in
combination with an antisense primer spanning the junction between
exons 32 and 34 and consisting of the last seven bases of exon 32 and the
®rst 13 bases of exon 34 (5¢-GCTCCTGGTTCACCCTGAGG-3¢) (Pr
32:34R). Ampli®cation was carried out under highly stringent conditions
to avoid mispriming of primer Pr 32:34R with the full-length COL17A1
transcript. PCRs were performed in a ®nal volume of 25 ml containing
1 mM MgCl2, 25 pmol of each primer, 200 mM dNTP, and 2 U of
AmpliTaq Gold DNA polymerase (Perkin Elmer). PCR cycling conditions
were 94°C for 10 min, followed by 94°C for 30 s, 68°C for 30 s, and 72°C
for 30 s (35 cycles). Both sets of PCRs were also performed on a cloned
wild-type cDNA fragment spanning exons 26±34, as a control. The
ampli®ed products were analyzed on a 2% agarose gel and all were
subjected to direct sequencing. To verify cDNA quality, ampli®cation of
the housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
transcript was carried out using the sense primer 5¢-TGGTAT-
CGTGGAAGGACTCATGAC-3¢ and antisense primer 5¢-ATGCCAGT-
GAGCTTCCCGTTCAGC-3¢ (annealing temperature 55°C).
Northern blot analysis Poly A+ RNA puri®ed from 0.4 mg of total
RNA (Fast Trackq 2, Invitrogen) was subjected to northern blot analysis as
described by Chavanas et al (1997). Quanti®cation of the hybridization
signals was performed by densitometric scanning using a GS-750
densitometer (Biorad, Hercules, CA).
Immunoblotting analysis Keratinocytes were grown in serum-free
medium until subcon¯uence, lyzed with cold water containing 20 U per ml
benzonase (Boehringer Mannheim, Mannheim, Germany), and then
extracted with sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) sample buffer. Protein extracts were separated on 5%
acrylamide slabgels, electrophoretically transferred to nitrocellulose ®lters,
and stained with MoAb 1A8C. The molecular weight of type XVII
collagen was assessed by mixing in biotinylated marker proteins, as
described by Pas et al (1997).
Haplotype analysis To determine the haplotype of the non-Herlitz JEB
patients, polymorphic microsatellites D10S577, D10S603, D10S222,
D10S566, D10S534, and D10S597, ¯anking the COL17A1 locus on
chromosome 10 (from the Genome database), and the intragenic
microsatellite marker COL17A1-CA1 (Scheffer et al, 1997) were used.
PCRs were performed using [a-32P]dCTP for labeling, followed by
electrophoresis on 6% polyacrylamide-8 M urea gel. The intragenic
COL17A1 intron 16 BstUI, intron 28 NlaIV, intron 54 BfaI restriction
fragment length polymorphisms were analyzed by PCR ampli®cation of
total genomic DNA from family members, using primers, restriction
enzymes, and conditions as described by Gatalica et al (1997).
RESULTS
Non-Herlitz JEB patients' skin displays residual collagen
XVII immunoreactivity Immuno¯uorescence analysis of
perilesional skin biopsies from the patients showed that,
compared with normal control skin, the anticollagen XVII
MoAbs 1A8C, 1D1, and 233 all reacted with greatly reduced
intensity to the BMZ (not shown) (Mazzanti et al, 1998).
In all patients mutation analysis shows homozygosity for a
nonsense mutation in COL17A1 exon 33, which results in
two mRNA forms: a normal length mRNA carrying the
mutation and an internally shortened transcript carrying the
in-frame skipping of exon 33 As collagen XVII expression was
markedly reduced in the skin of all patients, search for mutation was
initiated by RT-PCR ampli®cation of the entire COL17A1 open
reading frame. In all patients, agarose gel electrophoresis of the
ampli®cation products corresponding to the cDNA region
encompassing exons 26±34 showed two bands, a 394 bp band
also present in the healthy controls, and an additional 358 bp fast-
migrating fragment, unique to the patients. Nucleotide sequencing
of the 358 bp cDNA fragment identi®ed an in-frame deletion (36
bp) corresponding to the sequence encoded by the entire exon 33
(Fig 1a). Sequence analysis of the 394 bp cDNA fragment
identi®ed a C®T substitution at position 2488 of COL17A1
cDNA sequence (GenBank no M91669) (Giudice et al, 1992)
(Fig 1a). The 2488C®T transition converts a codon (CGA) for
arginine to a premature termination codon (PTC) and predicts a
type XVII collagen polypeptide truncated at residue 795 within the
®fteenth collagenous subdomain (Col15) of the extracellular
region. This mutation was therefore designated R795X
(GenBank no. AAB51499) (Gatalica et al, 1997). In all the
patients, direct sequencing of the genomic DNA fragment
encompassing exon 33 and the ¯anking intronic boundaries
revealed homozygosity for transition 2488C®T (GenBank no.
U76564) (Gatalica et al, 1997) (Fig 1b). No other nucleotide
sequence variation was detected compared with unrelated healthy
controls.
The nucleotide substitution 2488C®T abolishes an HaeIII
endonuclease restriction site. We therefore assessed the inheritance
of this mutation in the four non-Herlitz JEB families by HaeIII
digestion. As shown in Fig 1(c), electrophoretic analysis of the
PCR products con®rmed the homozygosity of all patients for
mutation 2488C®T and revealed that the mother of patients A-
V.1 and A-V.2 and the healthy son of patient A-V.5 were
heterozygous carriers.
The COL17A1 exon 33-skipped transcripts are also
detectable in normal human keratinocytes In order to
investigate the mechanism leading to the skipping of the exon
carrying the nonsense mutation, RT-PCR-based tests were
performed. As shown in Fig 2(a), the use of the primers spanning
exons 26±34 on a panel of samples revealed the additional 358 bp
fragment corresponding to the in-frame exon 33-skipped transcript
in our patient (A-V.5) and, to a much lesser extent, in the
heterozygous carrier (A-VI.1) keratinocytes, but neither in normal
cells nor in the type XVII collagen-de®cient GABEB cells carrying
the homozygous frameshift mutation 2342delG (Scheffer et al,
1997). By using in a separate set of PCR ampli®cations a reverse
primer (Pr 32:34R) that spans the boundaries between exons 32
and 34, however, the exon 33-deleted transcripts were also
detected in normal human keratinocytes and in the 2342delG
GABEB cells (Fig 2b). These data indicate that the skipping of
exon 33 represents a constitutive process occurring at very low
level in all keratinocytes.
Northern analysis shows greatly reduced levels of type XVII
collagen mRNA in the patients Evaluation of the steady-state
level of type XVII collagen transcripts was performed by northern
blot analysis. Densitometric analysis of the hybridization bands
showed that the level of COL17A1 mRNA was reduced by about
184 RUZZI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
95% in patients A-V.5 and C-II.1 compared with healthy controls,
and even more in patients A-V.1 and A-V.2 (not shown).
Immunoblotting analysis evidences residual synthesis of
type XVII collagen molecules Immunoblot analysis of
cultured keratinocyte extracts with MoAb 1A8C, which binds to
the intracellular domain of type XVII collagen, showed in our
patients (A-V.5 and D-II.1) one band at ~180 kDa that was
expressed at low level compared with type XVII collagen from
normal control cells (Fig 3, lanes 1±3). By intensity scanning of
immunoblot signals of serially diluted protein samples, the type
XVII collagen expression level in our probands' cells was estimated
to be of the order of 3%±4% of the normal level. As expected, the
keratinocytes of the 2342delG GABEB patient did not show any
detectable protein (Fig 3, lane 4).
All patients share a common haplotype To determine
whether the shared occurrence of mutation R795X results from
the propagation of an ancestral allele or a mutational hot spot,
intragenic and extragenic polymorphic marker analysis was
performed on members of the four non-Herlitz JEB families
(Fig 1C). In families A and B a common homozygous haplotype
for the mutant allele was observed in all affected individuals (not
shown). Similarly, probands C-II.1 and D-II.1 also displayed the
shared haplotype, differing only for the more external ¯anking
markers, providing support for propagation of an ancestral allele
within the Italian population (not shown).
DISCUSSION
In the past few years defective expression of the hemidesmosomal
component type XVII collagen has been shown to correlate to a
variant of non-Herlitz (nonlethal) JEB formerly named GABEB,
characterized by widespread skin blistering healing with atrophy,
mild mucosal lesions, and dystrophic nails and teeth (Jonkman et al,
1995; Pohla-Gubo et al, 1995). Atrophic alopecia, almost invariably
present, has been considered for a long time the distinctive
phenotypic manifestation of the disease (Jonkman et al, 1996).
Altered collagen XVII expression has also been shown to result in
more localized JEB forms, however, with predominantly acral
blistering and normal hair (Schumann et al, 1997). So far a number
of mutations in the gene encoding type XVII collagen, COL17A1,
have been identi®ed in these GABEB patients (Pulkkinen et al,
1999; references therein). In most cases, mutations consist of PTCs
affecting both alleles and resulting in the complete absence of
collagen XVII (Pulkkinen and Uitto, 1998). Nonsense mediated
decay of the abnormal transcripts has been shown to be responsible
for the lack of type XVII collagen at both the mRNA and protein
level in these patients (Darling et al, 1997; 1998b). On the other
hand, a few missense mutations that allow synthesis of mutant type
XVII collagen and can be compatible with its deposition along the
BMZ have also been identi®ed (Schumann et al, 1997; Floeth et al,
1998).
In this report, we describe the genetic defect underlying an
unusually mild clinical non-Herlitz JEB phenotype in six Italian
patients. In all probands, search for mutations demonstrated
homozygosity for a novel nonsense mutation (R795X) in exon
33 of COL17A1 gene consequent to a C®T base transition. In
these patients, the occurrence of the PTC in the coding sequence
of COL17A1 correlates with dramatically reduced levels of type
XVII collagen transcripts as detected by northern blot, in line with
nonsense mediated decay of the mRNA molecules encoding
truncated type XVII collagen polypeptides (Maquat, 1995; Darling
et al, 1997; 1998b; Hentze and Kulozik, 1999).
Interestingly, RT-PCR experiments evidenced two mRNA
species in patients' keratinocytes: the expected normal-length
transcript carrying mutation R795X and an additional transcript
carrying the in-frame deletion of exon 33. As using appropriate
PCR conditions we could also detect this exon 33-lacking
COL17A1 mRNA in normal keratinocytes, we conclude that this
Figure 2. Ampli®cation of exon 33 alternatively processed tran-
scripts in patients' and normal keratinocytes. Two percent agarose gel
fractionation of RT-PCRs of total RNA extracted from cultured
keratinocytes of four unrelated healthy donors (lanes 2±5), the heterozygous
healthy carrier A-VI.1 (lane 6), patient A-V.5 (lane 7), 2342delG GABEB
cells (lane 10), and from normal human lymphocytes (lane 1). Lane 8
corresponds to blank (no template added to the PCR). Lane 9 shows PCR
ampli®cation performed on a cloned wild-type cDNA fragment spanning
exons 26±34 as positive (a)/negative (b) control. Whereas with primers Pr
7L/Pr 7R encompassing exons 26±34 an additional 358 bp band is detected
only in the patient and, to a minor degree, in the healthy carrier (a), the use
of a primer pair Pr 7L/Pr 32:34R, the latter spanning the junction between
exons 32 and 34, evidences a 338 bp product, corresponding to the exon
33-deleted transcript, also in normal human keratinocytes and in 2342delG
GABEB cells (b). Identity of the 338 bp fragment shown in panel B was
checked by direct sequencing. (c) Ampli®cation of GAPDH served as
cDNA quality control. A 100 bp ladder (Boehringer Mannheim) was used
as molecular size marker.
Figure 3. Immunoblot detection of residual type XVII collagen in
patients' keratinocytes. Protein extracts of normal and patients'
keratinocytes were separated by SDS-PAGE, transferred to nitrocellulose
®lters, and stained for type XVII collagen (BP180) expression using MoAb
1A8C. Lane 1, extract from normal cells (four times diluted); lane 2, extract
from patient A-V.5 cells; lane 3, extract from patient D-II.1 cells; lane 4,
extract from 2342delG GABEB cells.
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transcript indeed represents a minor constitutive alternatively
processed mRNA variant. Thus, in both our non-Herlitz JEB
patients and the heterozygous healthy carrier, the strong reduction
of full-length R795X mRNA allows more ef®cient ampli®cation
of the minor exon 33-deleted transcript (Valentine and He¯ich,
1997). By contrast, in the 2342delG GABEB cells the transcript
lacking exon 33 can only be detected by the use of speci®c
boundary primers, indicating that in these cells either COL17A1
transcripts undergo to nonsense mediated mRNA decay. This
®nding is in line with both full-length and exon 33-deleted
transcripts carrying a PTC in exon 33 and exon 34, respectively, as
a consequence of the frameshift mutation 2342delG.
As a result of the in-frame skipping of exon 33, the encoded type
XVII collagen polypeptide should have a molecular mass of
~179 kDa due to the deletion of 12 amino acid residues in the
Col15 subdomain. As the deletion does not disrupt the Gly-X-Y
collagenous motif, this shorter molecule is theoretically still capable
of folding into a triple helix. Although the very low amount of
alternatively spliced COL17A1 mRNA detected in the keratino-
cytes of healthy donors does not argue in favor of a physiologic
function for the exon 33-deleted collagen XVII form, we cannot
exclude a developmental role and/or a tissue-speci®c regulation of
the internally shortened protein.
In our patients, immunoblotting experiments detected type
XVII collagen molecules with a molecular mass of approximately
180 kDa. As no other polypeptide was visualized, we conclude that
the residual protein evidenced by immunoblot represents the
translation product of the minor mRNA transcript, which
constitutively splices out the exon harboring the mutation, and
that the transcript carrying the nonsense mutation R795X does not
result in any detectable protein. The immuno¯uorescence analysis
of our probands' skin is also in keeping with synthesis and secretion
of the exon 33-deleted type XVII collagen as a faint staining was
visualized with both monoclonal antibodies to the cytoplasmic
domain (1A8C) and to the carboxy-terminal end of the molecule
(1D1).
All together, our data indicate that the disease condition is
primarily caused by reduction in the level of full-length collagen
XVII mRNA carrying mutation R795X, and that the minor form
of type XVII collagen transcripts bearing the internal deletion of
exon 33 may account for the unusually mild clinical phenotype of
our probands. Indeed, genetic diseases in which the deleterious
consequences of nonsense or frameshift mutations are mitigated by
alternatively processed transcripts encoding at least partially
functional polypeptides have already been reported (Morisaki et al,
1993; McGrath et al, 1999).
Finally, we show that mutation R795X shared by four Italian
non-Herlitz JEB families exhibits a common haplotype for
polymorphisms within and near COL17A1 indicating a founder
effect. The propagation of ancestral alleles has already been
demonstrated for recurrent mutations in COL17A1 in Dutch/
German/Norwegian (Scheffer et al, 1997) and in Austrian (Darling
et al, 1998a) families. Therefore, Italian patients affected with
epidermolysis bullosa and showing a defective expression of type
XVII collagen should ®rst be screened for the presence of mutation
R795X.
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